Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 1

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-60805-857-0 (Print)
ISBN: 978-1-60805-856-3 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080585631140101

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The first volume of this series features 6 chapters that cover a variety of topics including:

  • - Angiotensin blockers
  • - Agents targeting advanced glycation end products
  • - Drugs and the peroxisome proliferator activated receptors
  • - Topical Drugs for diabetic complications
  • - Research on Liraglutide
  • - Research on MicroRNAs as agents for diabetes treatment

Preface

- Pp. i-iii (3)
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. iv-v (2)
Atta-ur-Rahman
Download Free

Angiotensin Blockers and Renoprotection in Diabetic Chronic Kidney Disease is a Failed Paradigm? – A Revisionist View of Renoprotection in Diabetic Chronic Kidney Disease and A Novel Classification Scheme for Renoprotective Agents

- Pp. 3-32 (30)
Macaulay A.C. Onuigbo

PDF Price: $30

View Abstract Purchase Chapter

New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)

- Pp. 33-66 (34)
Emilia Liao, Agustin Busta, Ashutosh Pareek and Leonid Poretsky

PDF Price: $30

View Abstract Purchase Chapter

Liraglutide: Present and Future

- Pp. 67-120 (54)
Dan Mircea Cheţa, Cristian Serafinceanu and Cornelia Zetu

PDF Price: $30

View Abstract Purchase Chapter

MicroRNA, A Diligent Conjurer in the Exposition of Diabetes

- Pp. 121-148 (28)
Puneetpal Singh

PDF Price: $30

View Abstract Purchase Chapter

Drugs and the Peroxisome Proliferator Activated Receptors

- Pp. 149-210 (62)
Kevin Stuart, Andrew Hartland, Mithun Bhartia and Sudarshan Ramachandran

PDF Price: $30

View Abstract Purchase Chapter

Topical Drugs for Diabetic Complications Current and Future

- Pp. 211-288 (78)
Ryuhei Sano and Tomohiko Sasase

PDF Price: $30

View Abstract Purchase Chapter

Index

- Pp. 289-309 (21)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Phytotherapy in the Management of Diabetes and Hypertension.
.Phytotherapy in the Management of Diabetes and Hypertension.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Understanding Obesity: From its Causes to Impact on Life.